Abalone Bio

📍 Emeryville, United States🗓 Founded 2017👥 20 employees💰 Last funded May 2020
The remarkable specificity and safety of antibody drugs have been limited to blocking inactivators for the largest class of drug targets. Abalone Bio develops antibody drugs that activate, enabling us to turn on previously inaccessible biological activities like anti-cancer or anti-inflammatory actions.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2017
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Abalone Bio?
Abalone Bio has 2 investors on record on gritt.io, 2 mid-stage.
When did Abalone Bio last raise funding?
The most recent investment in Abalone Bio recorded on gritt.io was in May 2020.
When was Abalone Bio founded?
Abalone Bio was founded in 2017.
What industry is Abalone Bio in?
Abalone Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Abalone Bio based?
Abalone Bio is headquartered in Emeryville, United States.